Papa-deine #3

   
Google
 
Web NewDrugInformation.com

Papa-deine #3


Drug - Papa-deine #3
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Acetaminophen; Codeine Phosphate
Multiple ingredients are in alphabetical order.

Strength - 300MG;30MG
The potency of the active ingredient(s), Acetaminophen; Codeine Phosphate. May repeat for multiple part products.

Applicant - VANGARD
The firm name holding legal responsibility for Papa-deine #3. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 088037
The FDA assigned number to Papa-deine #3. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Papa-deine #3. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 20, 1984
The date Papa-deine #3 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Papa-deine #3. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Papa-deine #3 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Vangard Laboratories Inc Div Midway Medical Co
The full name of the firm holding legal responsibility for the new application of Papa-deine #3.

Papa-deine #3